Lepage S - Search Results

1

Blood oxidative stress in amyotrophic lateral sclerosis.

Bonnefont-Rousselot D, Lacomblez L, Jaudon M, Lepage S, Salachas F, Bensimon G, Bizard C, Doppler V, Delattre J, Meininger V. Bonnefont-Rousselot D, et al. Among authors: lepage s. J Neurol Sci. 2000 Sep 1;178(1):57-62. doi: 10.1016/s0022-510x(00)00365-8. J Neurol Sci. 2000. PMID: 11018250 Clinical Trial.

2

Protection of endogenous beta-carotene in LDL oxidized by oxygen free radicals in the presence of supraphysiological concentrations of melatonin.

Bonnefont-Rousselot D, Guilloz V, Lepage S, Bizard C, Duriez P, Lesieur D, Delattre J, Jore D, Gardès-Albert M. Bonnefont-Rousselot D, et al. Among authors: lepage s. Redox Rep. 2003;8(2):95-104. doi: 10.1179/135100003125001413. Redox Rep. 2003. PMID: 12804012 Free article.

3

Effect of pH on low-density lipoprotein oxidation by O2-./HO2. free radicals produced by gamma radiolysis.

Bonnefont-Rousselot D, Gardès-Albert M, Lepage S, Delattre J, Ferradini C. Bonnefont-Rousselot D, et al. Among authors: lepage s. Radiat Res. 1992 Nov;132(2):228-36. Radiat Res. 1992. PMID: 1332113

4

[Peroxidation of human high density lipoproteins by oxygen-derived free radicals].

Delattre J, Bonnefont-Rousselot D, Khalil A, Lepage S, Gardes-Albert M, Ferradini C. Delattre J, et al. Among authors: lepage s. Bull Acad Natl Med. 1993 Oct;177(7):1251-60; discussion 1260-2. Bull Acad Natl Med. 1993. PMID: 8149261 French.

5

Antioxidant status of hypercholesterolemic patients treated with LDL apheresis.

Lepage S, Bonnefont-Rousselot D, Bruckert E, Bourely B, Jaudon MC, Delattre J, Assogba U. Lepage S, et al. Cardiovasc Drugs Ther. 1996 Nov;10(5):567-71. doi: 10.1007/BF00050998. Cardiovasc Drugs Ther. 1996. PMID: 8950072 Clinical Trial.

6

[The plasma antioxidant status and trace elements in patients with familial hypercholesterolemia treated with LDL-apheresis].

Delattre J, Lepage S, Jaudon MC, Bruckert E, Assogba U, Bonnefont-Rousselot D. Delattre J, et al. Among authors: lepage s. Ann Pharm Fr. 1998;56(1):18-25. Ann Pharm Fr. 1998. PMID: 9770031 Clinical Trial. French.

7

Modifications of alpha-tocopherol and fatty acid concentrations in blood and adipose tissue of obese patients during a weight loss programme.

Bonnefont-Rousselot D, Lepage S, Thérond P, Bastard JP, Hainque B, Turpin G, Legrand A, Delattre J, Bruckert E. Bonnefont-Rousselot D, et al. Among authors: lepage s. Nutr Metab Cardiovasc Dis. 1999 Feb;9(1):25-32. Nutr Metab Cardiovasc Dis. 1999. PMID: 10726106 Clinical Trial.

8

Blood antioxidants (vitamin E and beta-carotene) in long-term low density lipoprotein apheresis.

Assogba U, Lepage S, Bruckert E, Bonnefont-Rousselot D, Dairou F, de Gennes JL, Delattre J. Assogba U, et al. Among authors: lepage s. Clin Chim Acta. 1995 Mar 31;235(2):147-57. doi: 10.1016/0009-8981(95)06021-9. Clin Chim Acta. 1995. PMID: 7554269

9

Oxidizability of atherogenic low-density lipoprotein subspecies in severe familial hypercholesterolemia: impact of long-term low-density lipoprotein apheresis.

Lepage S, Nigon F, Bonnefont-Rousselot D, Assogba U, Goulinet S, Chancharme L, Delattre J, Bruckert E, Chapman MJ. Lepage S, et al. J Cardiovasc Pharmacol Ther. 2000 Apr;5(2):87-103. doi: 10.1053/XV.2000.5588. J Cardiovasc Pharmacol Ther. 2000. PMID: 11150388 Clinical Trial.

10

Simple method for quantifying alpha-tocopherol in low-density+very-low-density lipoproteins and in high-density lipoproteins.

Carcelain G, David F, Lepage S, Bonnefont-Rousselot D, Delattre J, Legrand A, Peynet J, Troupel S. Carcelain G, et al. Among authors: lepage s. Clin Chem. 1992 Sep;38(9):1792-5. Clin Chem. 1992. PMID: 1526016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters